Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

The Justice Department could push for the tech giant to sell off a business to end its lock on online search. But a move ...

Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the ...

In a bid to reshape Pfizer’s future, activist investor Starboard Value has acquired a stake worth approximately $1 billion, ...

Pfizer shares rise on report of activist investor stake, ExxonMobil stock adds to record highs as oil prices continue surge, ...

Pfizer’s CEO reflects on a year of discovery and what he thinks critics get wrong about vaccine pricing Albert Bourla talks about his employees' effort to develop a COVID-19 vaccine in record ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Albert Bourla could be seen saying ... But the clip had been taken out of context from a longer interview, with Yahoo Finance, in which Mr Bourla had been discussing high infection rates with ...

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

A top EU court said Monday that it would hear a lawsuit next month over the release of private text messages that European Commission chief Ursula von der Leyen sent to negotiate Covid vaccine ...

Friday’s announcement represents a shift in tone for the company and its leader, who has repeatedly emphasized the month of October in interviews ... Dr. Albert Bourla, said the drug-making ...

Albert Bourla said Pfizer expects to price its treatment, called Paxlovid, close to where rival Merck & Co Inc has priced its oral antiviral drug candidate. The companies said the vaccine ...